IRS 990 Nonprofit Profile
Drugs For Neglected Diseases Initiative North America INC
The drugs for neglected diseases initiative (dndi), north america supports dndi's global vision and mission to develop new drugs, or new formulations of existing drugs for patients suffering from the most neglected diseases. acting in the public interest, dndi bridges existing r&d gaps in essential drugs for these diseases by initiating and coordinating drug r&d projects in collaboration with the international research community, the public sector, the pharmaceutical industry, and other partners.
- Filing year
- 2024
- Total revenue
- $6.2M
- Total expenses
- $6.3M
- Program expenses
- $5.1M
- Administration
- $643K
- Fundraising
- $589K
- Program share of expenses
- 81%
- EIN
- 208774179
- Location
- New York, NY
About CharitySense
CharitySense provides live, independent intelligence from the charitable infrastructure you fund — hospitals, schools, orphanages, and clinics anywhere in the world.
See live projects or read our insights on nonprofit accountability.
Financial data on this page is sourced from IRS Form 990 filings.